Contact Information: Contact: digiMedical Solutions, Inc. Investor Relations ir@digimedical.com 214-722-3029 Sales: sales@digimedical.com 1-877-450-8181
digiMedical Solutions, Inc. Rolls Out Easy-to-Use, Next Generation Prescription Software and Call Center Services for Cardiologist Dr. Barry Schiff
| Source: digiMedical Solutions, Inc.
COLLEYVILLE, TX--(Marketwire - October 30, 2008) - digiMedical Solutions, Inc. (PINKSHEETS : DGMS ) today announced that the Company has rolled out its next generation
prescription handling software and unique prescription reauthorization call
center services for cardiologist Dr. Barry Schiff of the University Heart
Institute in Pembroke Pines, Florida.
digiMedical's Next Generation Prescription Handling Software
digiMedical provides an easy-to-use, digital prescription toolset to both
doctors and pharmacies to streamline the prescription process. Doctors use
a handheld device or desktop computer to easily and quickly 'write' a
prescription, which is then securely transmitted directly to the pharmacy
of the patient's choosing. The medication and pharmacy choices are all
preloaded in the system, customized to the doctor's location and needs.
The software meets all HIPAA and DEA requirements and helps protect both
the doctor and pharmacist from errors caused by difficult-to-read
handwritten prescriptions and the risk of illegally duplicated
prescriptions and fraudulent prescriptions.
Pharmacies that also use the digiMedical software will receive the
prescription quickly and securely, with all pertinent patient information,
allowing the pharmacy to pre-fill the prescription prior to the patient's
arrival at the pharmacy and better track and forecast pharmaceutical supply
needs. Other pharmacies, not yet using digiMedical software, receive the
prescription via secure fax.
To learn more about the software's robust features, please contact the
company at sales@digimedical.com or 1-877-450-8181. The software is
compatible with most medical office software and is easy to install and
learn to use.
digiMedical's Prescription reauthorization Call Center Services
Additionally, digiMedical manages prescription refills for physicians'
offices and clinics through the Company's unique digiReauth software and
call center services. Doctors can significantly reduce their own staff's
prescription re-authorization workload by outsourcing it to digiMedical's
call center, freeing their staff up to focus on patient care.
More Information on Digitally Secure, End-to-End Prescription Handling
digiMedical's leading edge, digitally secure prescription handling
software, which is currently in use in doctors' offices, clinics, and
pharmacies in Naples, Ft. Meyers, and Fort Lauderdale, Florida, and in
Dallas, Texas, is now available for implementation nationwide. If you are a
doctor or pharmacist interested in learning more about digiMedical's
software, or implementing the Company's proprietary technology in your
office, clinic or pharmacy, please contact the Company at
sales@digimedical.com or 1-877-450-8181.
To be added to digiMedical's corporate e-mail list for shareholders and
interested investors or to request additional information about the
Company, please send an e-mail to ir@digimedical.com.
About digiMedical Solutions, Inc.™
digiMedical Solutions, Inc.™ (www.digimedical.com) is a pharmacy and
medical technology company focused on developing next generation digital
medical technology with an emphasis on digital prescriptions
(d-Prescriptions) that will more closely align the doctor, pharmacist and
patient. The Company's digital prescription handling software captures and
transmits prescriptions digitally from the physician's office to the
pharmacy, securely and in compliance with all DEA and HIPAA requirements.
The suite of software includes digiRX, digiRxStream, digiReauth,
digiRxComp, and digiAccounting.
Forward-Looking Statement
Statements included in this press release which are not historical in
nature, are intended to be, and are hereby identified as "Forward-Looking
Statements" for purposes of safe harbor provided by Section 21E of the
Securities Exchange Act of 1934, as amended. Forward-Looking Statements may
be identified by words including "anticipate," "await," "envision,"
"foresee," "aim at," "believe," "intends," "estimates" including without
limitation, those relating to the company's future business prospects, are
subject to certain risks and uncertainties that could cause actual results
to differ materially from those indicated in the Forward-Looking
Statements. Readers are directed to the company's filings with the U.S.
Securities and Exchange Commission for additional information and a
presentation of the risks and uncertainties that may affect the company's
business and results of operations.